Using data from The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC), we explored the relationship between tumors with ARID1A mutations and NRF2 signaling because ARID1A is the most frequently mutated SWI/SNF subunit. This evidence concerns the gene ARID1A and neoplasm.